Nippon Seika to Present at the 112th Meeting of the Flow Micro Synthesis Study Group
Nippon Seika Co., Ltd. will present on its high-efficiency continuous production technology for ionized lipids used in nucleic acid DDS at the "Flow Micro Synthesis Study Group" meeting on April 23, 2026. This highlights advancements in manufacturing processes for pharmaceutical development.
📋 Article Processing Timeline
- 📰 Published: April 3, 2026 at 19:00
Nippon Seika Co., Ltd. (Headquarters: Osaka City, Osaka Prefecture; Representative Director, President & CEO: Hiroshi Yano) will be presenting at the "Flow Micro Synthesis Study Group 112th Meeting," to be held on Thursday, April 23, 2026, at the Osaka Science and Technology Center.
■ Flow Micro Synthesis Study Group
The Flow Micro Synthesis Study Group is a research group that aims to expand the application of microreactor technology in the chemical and pharmaceutical fields by sharing information and exchanging opinions on new synthesis and manufacturing technologies using microreactors. It fosters collaboration between industry and academia, promoting the development of the field through the sharing of the latest technologies and case studies.
■ Presentation Details
- Presentation Title: High-efficiency continuous production of ionized lipids for nucleic acid DDS using flow technology
- Presentation Date/Time: Thursday, April 23, 2026, 14:00–15:00
- Format:
- In-person: Room 700, 7th Floor, Osaka Science and Technology Center (1-8-4 Utsubohonmachi, Nishi-ku, Osaka City)
Access: https://www.ostec.or.jp/ostec-room/access
- Online: Live streaming via Zoom
- Presenter: Yuki Teshima (Nippon Seika Co., Ltd., Lipid Business Division)
At the event, we will introduce examples of our microreactor utilization in the continuous production process for ionized lipids that our company has developed.
We sincerely look forward to your attendance.
Nippon Seika Co., Ltd.
Company Profile
- Headquarters: 10F Nippon Seika Building, 2-4-9 Bingomachi, Chuo-ku, Osaka City, Osaka Prefecture
- Representative Director, President & CEO: Hiroshi Yano
- Listed: TSE Prime
- Capital: 5.93322 billion JPY
- Established: February 1918
- Business Description: Manufacturing and sales of functional products and environmental sanitation products, real estate leasing.
- Website: https://www.nipponseika.co.jp/
- Official Instagram: https://www.instagram.com/nfc_corporate_official/
FAQ
What technology will Nippon Seika present on?
They will present on high-efficiency, continuous production of ionized lipids for nucleic acid DDS using microreactors with flow technology.
What is the purpose of this presentation?
To introduce application examples of new synthesis/manufacturing technologies using microreactors and aim for expanded utilization in the chemical and pharmaceutical fields.
Where will the presentation be held?
It will be held on April 23, 2026, at the Osaka Science and Technology Center, both in-person and online via Zoom.